Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 866 JPY 2.93%
Market Cap: 676.9B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rohto Pharmaceutical Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Operating Income
ÂĄ36.9B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
10%
Shiseido Co Ltd
TSE:4911
Operating Income
ÂĄ46.8B
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
2%
Kao Corp
TSE:4452
Operating Income
ÂĄ110.4B
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-1%
Kose Corp
TSE:4922
Operating Income
ÂĄ18.8B
CAGR 3-Years
1%
CAGR 5-Years
-18%
CAGR 10-Years
0%
F
Fancl Corp
TSE:4921
Operating Income
ÂĄ11.3B
CAGR 3-Years
-2%
CAGR 5-Years
-5%
CAGR 10-Years
12%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Operating Income
ÂĄ23.4B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
3%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
653.8B JPY
Industry
Consumer products

Rohto Pharmaceutical Co Ltd., a company deeply rooted in the legacy of Japanese innovation, traces its beginnings to the late 19th century. Initially specializing in over-the-counter (OTC) medicines, it has adeptly expanded its reach to include skincare and healthcare products. The company’s journey from its inception was marked by a relentless pursuit of addressing the evolving needs of its consumer base, leveraging its expertise in pharmaceuticals and chemistry to create products that cater to health and wellness. Rohto's commitment to research and development has enabled it to pioneer unique formulations, effectively blending traditional practices with modern scientific advances. This strategy has allowed Rohto to establish a strong foothold not only in Japan but also in international markets, appealing to a broad demographic. The core of Rohto's business lies in its ability to commercialize its innovative solutions across various channels. The company generates revenue primarily through the sale of its diversified product lines, which include eye drops, dermatological creams, and other personal care products. Rohto’s strategic acquisitions and partnerships have also played a critical role in its growth, enabling it to expand its market presence and adapt to global health trends. The ability to anticipate and respond to consumer needs allows Rohto to maintain a robust product pipeline, ensuring consistent sales performance. Through its global distribution networks and focused marketing efforts, Rohto capitalizes on its brand reputation for quality and reliability, ensuring a steady stream of profits.

Intrinsic Value
3 209.06 JPY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Operating Income?
Operating Income
36.9B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Operating Income amounts to 36.9B JPY.

What is Rohto Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was -5%. The average annual Operating Income growth rates for Rohto Pharmaceutical Co Ltd have been 12% over the past three years , 12% over the past five years , and 10% over the past ten years .

Back to Top